Evidence map›Paper›PMID 16434972›Full record

ArticleOncogene2006

E2F1 induces MRN foci formation and a cell cycle checkpoint response in human fibroblasts.

F M Frame, H A Rogoff, M T Pickering, W D Cress, T F Kowalik

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Tug of war between survival and death: exploring ATM function in cancer.International journal of molecular sciences · 2014
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Cellular aging and cancer.Critical reviews in oncology/hematology · 2011
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

F M FrameDepartment of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester, 01655, USA.
H A Rogoff
M T Pickering
W D Cress
T F Kowalik
University of Massachusetts Chan Medical School · USMoffitt Cancer Center · US

Funding

PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
Transcriptional Control of Mcl-1 and Bok/Mtd by E2F1R01CA090489 · NCI · H. LEE MOFFITT CANCER CTR &RES INST · PI CRESS, WILLIAM D · 2003 to 2007
$1.6M
E2F AND APOPTOSISR01CA086038 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KOWALIK, TIMOTHY F · 2000 to 2004
$1.4M
DETECTION AND SIGNIFICANCE OF SI VARIANTS OF HIVF32AI009749 · NIAID · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI NELSON, JULIE A · 1998 to 1998
–
NCI NIH HHS CA86038NCI NIH HHS CA90489NIAID NIH HHS 5T32 AI09749NIDDK NIH HHS DK32520
6 · The paper itself

Abstract

Deregulation of the Rb/E2F pathway in human fibroblasts results in an E2F1-mediated apoptosis dependent on Atm, Nbs1, Chk2 and p53. Here, we show that E2F1 expression results in MRN foci formation, which is independent of the Nbs1 interacting region and the DNA-binding domain of E2F1. E2F1-induced MRN foci are similar to irradiation-induced foci (IRIF) that result from double-strand DNA breaks because they correlate with 53BP1 and gammaH2AX foci, do not form in NBS cells, do form in AT cells and do not correlate with cell cycle entry. In fact, we find that in human fibroblasts deregulated E2F1 causes a G1 arrest, blocking serum-induced cell cycle progression, in part through an Nbs1/53BP1/p53/p21(WAF1/CIP1) checkpoint pathway. This checkpoint protects against apoptosis because depletion of 53BP1 or p21(WAF1/CIP1) increases both the rate and extent of apoptosis. Nbs1 and p53 contribute to both checkpoint and apoptosis pathways. These results suggest that E2F1-induced foci generate a cell cycle checkpoint that, with sustained E2F1 activity, eventually yields to apoptosis. Uncontrolled proliferation due to Rb/E2F deregulation as well as inactivation of both checkpoint and apoptosis programs would then be required for transformation of normal cells to tumor cells.

Indexed as

Acid Anhydride HydrolasesApoptosisCell CycleCell Cycle ProteinsCell LineCyclin-Dependent Kinase Inhibitor p21DNA-Binding ProteinsDNA DamageDNA RepairDNA Repair EnzymesE2F1 Transcription FactorFibroblastsHumansIntracellular Signaling Peptides and ProteinsMRE11 Homologue ProteinNuclear ProteinsAcid Anhydride HydrolasesCDKN1A protein, humanCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p21DNA-Binding ProteinsDNA Repair EnzymesE2F1 protein, humanE2F1 Transcription FactorIntracellular Signaling Peptides and ProteinsMRE11 Homologue ProteinMRE11 protein, humanNBN protein, humanNuclear ProteinsPhosphoproteinsRAD50 protein, humanTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1Tumor Suppressor Protein p53

Identifiers

PMID16434972
OpenAlexW1998070942

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.